Zobrazeno 1 - 10
of 20
pro vyhledávání: '"K Kruntoradova"'
Autor:
Marie Trnkova, Petra Keslova, Marek Trneny, Miriam Lánská, Marta Krejčí, Petr Cetkovsky, Kateřina Steinerová, Veronika Valkova, T Dolezal, K Kruntoradova, Korístek Z, J Jircikova, K Benesova, Luděk Raida
Publikováno v:
Neoplasma. 63(5)
UNLABELLED Although allogeneic haematopoietic stem cell transplantation (allo-HSCT) offers a unique curative potential, it may be connected with high treatment-related morbidity and mortality. Besides many organ complications, allo-HSCT may significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80bb73b7f49884d50736930ca4272b5
https://pubmed.ncbi.nlm.nih.gov/27468878
https://pubmed.ncbi.nlm.nih.gov/27468878
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2facaf186431f2eafbfafd866a07dc6
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08036e315820b885f38e75870a739c4d
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1fa212f0df9729a00a381fed7963f4
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2c8911587ae6a905c6226ea205e9072
Publikováno v:
Value in Health. 14(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3a9d106d9508cbe71e46a9488c3bd1
Publikováno v:
Value in Health. 18:A649
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd25b3e9e624910c4e152155794a87ba
https://doi.org/10.1016/j.jval.2015.09.2334
https://doi.org/10.1016/j.jval.2015.09.2334
Publikováno v:
Value in Health. 17:A397
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bcdd9cf98d498e8e4fe1cfa0658429
https://doi.org/10.1016/j.jval.2014.08.893
https://doi.org/10.1016/j.jval.2014.08.893
Publikováno v:
Value in Health. 17:A641
[1] Rummel, MJ et al.: Bendamustin plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. The Lancet 381, 1203-121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::524903a08ec66957087f4b01a377fe88
https://doi.org/10.1016/j.jval.2014.08.2314
https://doi.org/10.1016/j.jval.2014.08.2314
Publikováno v:
Value in Health. 14:A305
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4719c4d51a35a0a16ad015a4986e80
https://doi.org/10.1016/j.jval.2011.08.403
https://doi.org/10.1016/j.jval.2011.08.403